Medroxyprogesterone a

Defense Logistics Agency Troop Support Medical (Medical Supply Chain) is soliciting quotes through DIBBS for medroxyprogesterone acetate, NSN 6505-01-276-2029, under request for quotation SPE2DP27T0349, with quotes due November 18, 2026. The Set Aside line reads No Set-Aside Used, so the requirement carries no set-aside restriction.

Delivery is required within 20 days, FOB Destination, with inspection and acceptance at destination. The line item calls for one bottle (BT). The attachment summary places delivery at Fort Hood, Texas (W50YEF) and describes 100-count bottles of 2.5 mg tablets, USP, with a minimum shelf life of 31 months at receipt, and it names Pfizer Inc., Teva Pharmaceuticals USA Inc., Greenstone LLC, and Bryant Ranch Prepack as approved manufacturers. The item is FDA-regulated and requires technical and quality compliance with the DLA Master List of Technical and Quality Requirements.

Quotes above the micro-purchase threshold must comply with the Buy American Act and Balance of Payments Program under DFARS 252.225-7001. Packaging requires commercial packaging per ASTM D3951, marking per MIL-STD-129, and compliance with DLA Packaging Requirements (RP001) and Medical Marking Standard No. 1. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 106, dated November 3, 2026, and is classified under PSC 6505, Drugs and Biologicals.

The attachment summary reports prior awards to CAGE 00E55 at unit costs of $3.66 to $4.37 per bottle. No budget or award ceiling is stated. Quotes may be awarded before the return date, and offerors are encouraged to submit quantity ranges because demand is volatile and changes frequently. No evaluation criteria are stated in the notice.